BlueRun Ventures — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Blue Fever is a social platform designed for young people to express themselves and find mental health support through private AI conversations, group journaling, and peer support communities.
AI & Machine LearningHealthtechMental HealthSocialWellness & FitnessMarina del Rey, US
Lauren Tracy(Executive Officer)
Board seatJonathan Ebinger· per SEC Form D · $5.6M raise · filed Jun 2022
Co-investorsBackstage CapitalHalogen Ventures Management Company LlcMozilla VenturesTechstarsThe W FundAlexa Fund
San Francisco, US
Jonathan McNulty(Chief Executive Officer of Issuer's Manager)Garrett Camp(Director of Issuer's Manager)
Board seatJonathan Ebinger· per SEC Form D · filed Feb 2022
Hello Heart is an AI company that builds preventive heart health solutions to help people lower their cardiovascular risk.
AI & Machine LearningDigital HealthHealthtechMenlo Park, US
Maayan Cohen(Executive Officer, Director)inZiv Meltzer(Executive Officer, Director)
BoardCheryl Cheng(Director)Alex Morgan(Director)in
Board seatJohn Malloy· per SEC Form D · $70M raise · filed May 2022
Co-investorsAAF Management Ltd.IVP (Institutional Venture Partners)Khosla VenturesMaven VenturesResolute VenturesStripes
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.